Neurofilament light chain levels in MS: At the doorstep of clinical application.
作者信息
Dalmau Josep
出版信息
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 16;6(5). doi: 10.1212/NXI.0000000000000601. Print 2019 Sep.
Abstract
摘要
相似文献
1
Neurofilament light chain levels in MS: At the doorstep of clinical application.多发性硬化症中神经丝轻链水平：迈向临床应用的门槛。
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 16;6(5). doi: 10.1212/NXI.0000000000000601. Print 2019 Sep.
2
Blood biomarkers for multiple sclerosis: neurofilament light chain and beyond.用于多发性硬化症的血液生物标志物：神经丝轻链及其他。
EBioMedicine. 2024 Jun;104:105214. doi: 10.1016/j.ebiom.2024.105214.
3
Serum NFL levels should be used to monitor multiple sclerosis evolution - No.血清神经丝轻链水平应用于监测多发性硬化症的进展——否。
Mult Scler. 2020 Jan;26(1):19-21. doi: 10.1177/1352458519872891. Epub 2019 Oct 18.
4
Serum NfL levels should be used to monitor multiple sclerosis evolution - Yes.血清神经丝轻链水平应用于监测多发性硬化症的进展——是。
Mult Scler. 2020 Jan;26(1):17-19. doi: 10.1177/1352458519872921. Epub 2019 Oct 18.
5
Serum NFL levels should be used to monitor multiple sclerosis evolution - Commentary.血清神经丝轻链水平应用于监测多发性硬化症的进展——评论。
Mult Scler. 2020 Jan;26(1):21-22. doi: 10.1177/1352458519880471. Epub 2019 Oct 18.
6
Mounting evidence for a multiple sclerosis prodrome.多发性硬化症前驱期的证据越来越多。
Nat Rev Neurol. 2019 Dec;15(12):689-690. doi: 10.1038/s41582-019-0283-0.
7
Comparison of Simoa and Ella to assess serum neurofilament-light chain in multiple sclerosis.比较 Simoa 和 Ella 检测多发性硬化症患者血清神经丝轻链。
Ann Clin Transl Neurol. 2021 May;8(5):1141-1150. doi: 10.1002/acn3.51355. Epub 2021 Apr 8.
8
[Evaluation of serum neurofilament light chains levels for diagnosis, treatment monitoring and prognosis in multiple sclerosis].[血清神经丝轻链水平在多发性硬化症诊断、治疗监测及预后评估中的应用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):7-13. doi: 10.17116/jnevro20191191027.
9
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders.神经丝轻链血清水平反映了与MOG抗体相关疾病的疾病严重程度。
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1293-1296. doi: 10.1136/jnnp-2018-320287. Epub 2019 Apr 5.
10
Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.血清神经丝轻链和胶质纤维酸性蛋白在水通道蛋白 4 免疫球蛋白 G 阳性视神经脊髓炎谱系疾病和多发性硬化中的作用：一项队列研究。
J Neurochem. 2021 Dec;159(5):913-922. doi: 10.1111/jnc.15478. Epub 2021 Jul 28.
引用本文的文献
1
Suggestions for improving the design of clinical trials in multiple sclerosis-results of a systematic analysis of completed phase III trials.改善多发性硬化症临床试验设计的建议——对已完成的III期试验的系统分析结果
EPMA J. 2019 Nov 22;10(4):425-436. doi: 10.1007/s13167-019-00192-z. eCollection 2019 Dec.
本文引用的文献
1
Blood neurofilament light chain at the doorstep of clinical application.血液神经丝轻链迈向临床应用之际。
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 8;6(5):e599. doi: 10.1212/NXI.0000000000000599. eCollection 2019 Sep.
2
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS.多发性硬化症患者接受造血干细胞移植后，血清神经丝轻链会恢复正常。
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 8;6(5):e598. doi: 10.1212/NXI.0000000000000598. eCollection 2019 Sep.
3
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS.鞘内 B 细胞积累和轴突损伤可区分 MS 中基于 MRI 的良性和侵袭性发作。
Neurol Neuroimmunol Neuroinflamm. 2019 Jul 19;6(5). doi: 10.1212/NXI.0000000000000595. Print 2019 Sep.
4
Hepatitis E virus infections in patients with MS on oral disease-modifying treatment.口服疾病修正治疗的多发性硬化症患者中的戊型肝炎病毒感染。
Neurol Neuroimmunol Neuroinflamm. 2019 Jul 11;6(5). doi: 10.1212/NXI.0000000000000594. Print 2019 Sep.
5
Novel clinical features of glycine receptor antibody syndrome: A series of 17 cases.甘氨酸受体抗体综合征的新临床特征：17 例系列病例。
Neurol Neuroimmunol Neuroinflamm. 2019 Jul 1;6(5):e592. doi: 10.1212/NXI.0000000000000592. eCollection 2019 Sep.
6
Systemic inflammatory response syndrome and long-term outcome after intracerebral hemorrhage.全身炎症反应综合征与脑出血后的长期转归。
Neurol Neuroimmunol Neuroinflamm. 2019 Jul 1;6(5):e588. doi: 10.1212/NXI.0000000000000588. eCollection 2019 Sep.
Zotero 插件